These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 19515233

  • 21. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE, Ombrello AK, Burlingame RW, Pepmueller PH, Moore TL.
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [Abstract] [Full Text] [Related]

  • 22. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
    Moura CG, Mangueira CL, Cruz LA, Cruz CM.
    Nephron Clin Pract; 2011 Jun; 118(4):c355-60. PubMed ID: 21325866
    [Abstract] [Full Text] [Related]

  • 23. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
    Metwally IM, Eesa NN, Yacoub MH, Elsman RM.
    Adv Rheumatol; 2019 Mar 04; 59(1):10. PubMed ID: 30832710
    [Abstract] [Full Text] [Related]

  • 24. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].
    Tsanyan ME, Torgashina AV, Aleksandrova EN, Soloviev SK, Nasonov EL.
    Ter Arkh; 2013 Mar 04; 85(5):53-9. PubMed ID: 23819340
    [Abstract] [Full Text] [Related]

  • 25. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
    Elshweikh SA, Elkhouly RM, Shaalan MM, Shorbagy SH.
    Egypt J Immunol; 2014 Mar 04; 21(2):49-59. PubMed ID: 25812352
    [Abstract] [Full Text] [Related]

  • 26. [Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].
    Trendelenburg M, Schifferli JA.
    Praxis (Bern 1994); 1998 Dec 24; 87(51-52):1811-3. PubMed ID: 10025155
    [Abstract] [Full Text] [Related]

  • 27. Association between anti-C1q antibodies and glomerular tuft necrosis in lupus nephritis.
    Jourde-Chiche N, Daniel L, Chiche L, Burtey S, Mancini J, Jego S, San Marco M, Bardin N.
    Clin Nephrol; 2012 Mar 24; 77(3):211-8. PubMed ID: 22377252
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 30. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients.
    Gómez-Puerta JA, Ortiz-Reyes B, Urrego T, Vanegas-García AL, Muñoz CH, González LA, Cervera R, Vásquez G.
    Lupus; 2018 Apr 02; 27(4):637-646. PubMed ID: 29073812
    [Abstract] [Full Text] [Related]

  • 31. Clinical value of autoantibodies against C1q in children with glomerulonephritis.
    Kozyro I, Perahud I, Sadallah S, Sukalo A, Titov L, Schifferli J, Trendelenburg M.
    Pediatrics; 2006 May 02; 117(5):1663-8. PubMed ID: 16651321
    [Abstract] [Full Text] [Related]

  • 32. Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus.
    Moura CG, Lima I, Barbosa L, Athanazio D, Reis E, Reis M, Burlingame RW, Santiago MB.
    J Clin Lab Anal; 2009 May 02; 23(1):19-23. PubMed ID: 19140207
    [Abstract] [Full Text] [Related]

  • 33. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
    Yang XW, Tan Y, Yu F, Zhao MH.
    Nephrol Dial Transplant; 2012 Sep 02; 27(9):3552-9. PubMed ID: 22700716
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
    Gunnarsson I, Rönnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L.
    Br J Rheumatol; 1997 Jan 02; 36(1):32-7. PubMed ID: 9117171
    [Abstract] [Full Text] [Related]

  • 36. Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity.
    Bernstein KA, Kahl LE, Balow JE, Lefkowith JB.
    Clin Exp Immunol; 1994 Oct 02; 98(1):60-5. PubMed ID: 7923886
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC, Ho LY, Leung HW, Wong LG.
    Transl Res; 2010 Dec 02; 156(6):320-5. PubMed ID: 21078493
    [Abstract] [Full Text] [Related]

  • 39. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K, Niemir ZI, Polcyn-Adamczak M.
    Pol Arch Med Wewn; 2011 Sep 02; 121(9):287-95. PubMed ID: 21860370
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.